Covered recipient · General Payments record
MOTT P BLAIR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,189.30
- Reported across 349 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $528.72 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $237.12 | 6 |
| Lilly USA, LLC | $62.24 | 4 |
| Merck Sharp & Dohme Corporation | $53.32 | 3 |
| ABBVIE INC. | $45.05 | 3 |
| GlaxoSmithKline, LLC. | $37.39 | 2 |
| E.R. Squibb & Sons, L.L.C. | $31.82 | 2 |
| PFIZER INC. | $25.33 | 1 |
| Acerta Pharma LLC | $22.42 | 1 |
| Amgen Inc. | $14.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103333690 | CMS |
| ABBVIE INC. | $13.15 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103333692 | CMS |
| ABBVIE INC. | $15.95 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103333694 | CMS |
| Amgen Inc. | $14.03 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117508792 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.42 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105607881 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.91 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101548734 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.91 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101548789 | CMS |
| GlaxoSmithKline, LLC. | $19.70 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116635566 | CMS |
| GlaxoSmithKline, LLC. | $17.69 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116306463 | CMS |
| Lilly USA, LLC | $18.20 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135174851 | CMS |
| Lilly USA, LLC | $15.65 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135271473 | CMS |
| Lilly USA, LLC | $14.38 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135225651 | CMS |
| Lilly USA, LLC | $14.01 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135223223 | CMS |
| Merck Sharp & Dohme LLC | $15.95 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141826184 | CMS |
| Merck Sharp & Dohme LLC | $16.61 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141952291 | CMS |
| Merck Sharp & Dohme LLC | $20.76 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141566213 | CMS |
| Novo Nordisk Inc | $20.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097368186 | CMS |
| Novo Nordisk Inc | $19.16 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097178990 | CMS |
| Novo Nordisk Inc | $6.17 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097772782 | CMS |
| Novo Nordisk Inc | $122.13 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096733644 | CMS |
| Novo Nordisk Inc | $21.82 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097385160 | CMS |
| Novo Nordisk Inc | $47.45 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096662244 | CMS |
| PFIZER INC. | $25.33 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130949796 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.